ARWR: Germany patients get access to REDEMPLO (plozasiran)
ARWR says people living with familial chylomicronaemia syndrome (FCS) in Germany have access to REDEMPLO (plozasiran) as a new treatment option to reduce triglycerides.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.